Future Fields is a fly biotechnology company based in Edmonton, Canada, has raised $11.2 million in funding in a round led by Climate Capital, with participation from AgFunder, Toyota Ventures, Builders VC, Amplify Capital, BoxOne Ventures, Bee Partners, and Siddhi Capital. The company, founded in 2018, aims to revolutionize science with its biomanufacturing platform, the EntoEngine™, which is the first synthetic biology system in the world to use fruit flies for recombinant protein production.

Future Fields' mission is to change how we do science for humanity and the planet. The company is equipping industries with biomolecular tools that can help conduct sustainable, ethical, and economically feasible science.

Future Fields is a proud member of 1% for the Planet, a global organization that promotes smart environmental giving, and it also participates in the United Nations Global Compact initiative, which aims to align strategies and operations with universal principles on human rights, labor, environment, and anti-corruption.

With the recent funding, Future Fields plans to accelerate the development and commercialization of its EntoEngine™ technology, expanding its team and advancing its research and development efforts. To learn more about how Future Fields is transforming science for the future, visit us https://founderlodge.com/round/Future-Fields-raises-11200000-Unknown-2023-02-23-Matt-Anderson-Baron-OTc5NQ.